637 research outputs found

    A decade comparison of preterm motor performance at age 4

    Get PDF
    This was a prospective longitudinal study of two cohorts comprised of one full term and three premature infant groups born 10 years apart. Birth cohort, perinatal morbidity, and birth weight effects were investigated at age 4. Cohort 1 (1985–1989) had longer gestation, higher birth weight, and better Apgar scores than Cohort 2 (1996–1999), which had more intraventricular hemorrhage and bronchopulmonary dysplasia. Cohort and perinatal morbidity group, but not birth weight, predicted motor scores. Preterm Cohort 2 children had better oral motor, fine motor, and total motor scores, but lower visual motor integration scores than Cohort 1. Motor problems continue to affect preterm children at age 4, in particular those who experience perinatal morbidity, despite a decade of neonatal intensive care advancement

    Evaluation of peroxyacetic acid, liquid buffered vinegar, and cultured dextrose fermentate as potential antimicrobial interventions for raw chicken livers

    Get PDF
    This study aimed to evaluate the use of peroxyacetic acid (PAA), buffered vinegar (BV), and cultured dextrose fermentate (CDF) to reduce Salmonella on artificially inoculated raw chicken livers, one of the most consumed offal around the world. Samples were inoculated with a 5-strain cocktail of poultry-borne Salmonella to obtain 106 CFU/g and immersed for 90 s with agitation in one of the following treatments: distilled water (control), 450 ppm PAA, 2.0% (w/v) BV, or 1.5% (w/v) CDF, prior to storing at 4oC. Salmonella was enumerated on XLD agar and monitored for 14 days. Data were analyzed using analysis of covariance. After immersion, there was a significant Salmonella reduction (p \u3c .05) with all treatments, including the control. PAA resulted in the greatest numerical reduction at 0.65 ± 0.12 log; however, there were no significant differences in the reductions among all other treatments (p \u3e .05). After 14 days, higher numerical reductions were observed for PAA, but only when compared to CDF. Although similar reductions (p \u3e .05) were noted after 14 days except for CDF, Salmonella counts were lowest in all timepoints when PAA was used. PAA and CDF inhibited the growth of aerobic bacteria until day 3 while BV inhibited the growth up to 7 days. Regarding objective color, chicken livers immersed in PAA became lighter, but the difference was not sustained over time. No differences were observed in redness or yellowness values across any treatments

    Effects of high-pressure processing on cooked color and eating qualities of dark-cutting beef

    Get PDF
    High meat pH leads to an undercooked or an abnormal pink appearance in fully-cooked product. High-pressure processing (HPP) promotes protein denaturation. The objective was to evaluate the effects of HPP on cooked steak color and sensory attributes of dark-cutting beef. USDA Choice (mean pH = 5.5) and dark-cutting (mean pH = 6.3) strip loin sections were vacuum packaged and treated with 0 (no HPP), 300, 450, and 600 MPa of pressure for 90 s using chilled water. Steaks were randomly assigned to measure external cooked color, Warner- Bratzler shear force, and trained sensory panel. Applying 300 MPa of pressure improved ( P \u3c 0.05) redness of raw dark-cutting steaks compared with control. HPP treatments did not influence ( P \u3e 0.05) a∗ and chroma of the external cooked steak color. HPP treatments also did not affect ( P \u3e 0.05) initial juiciness, sustained juiciness, beef flavor intensity, or overall acceptability. However, 600 MPa made dark-cutting steaks tougher and lighter ( P \u3c 0.05) in appearance than all other treatments. In conclusion, low (300 MPa) and moderate (450 MPa) pressure levels improved raw steak redness without affecting the eating qualities of dark-cutting cooked steaks. HPP did not minimize the undercooked appearance commonly associated with high-pH beef

    Tribute to Professor Joan Shaughnessy

    Full text link
    A tribute to Professor Joan Shaughnessy, who served on the faculty of the Washington and Lee University School of Law from 1983 to 2022. A recognized scholar and teacher in areas of civil procedure, federal courts, evidence, family law, and poverty law, Shaun was appointed as W&L\u27s inaugural Roger D. Groot Professor of Law in 2012

    Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients

    Get PDF
    There is a paucity of data to support evidence-based practices in the provision of patient/family education in the context of a new childhood cancer diagnosis. Since the majority of children with cancer are treated on pediatric oncology clinical trials, lack of effective patient/family education has the potential to negatively affect both patient and clinical trial outcomes. The Children’s Oncology Group Nursing Discipline convened an interprofessional expert panel from within and beyond pediatric oncology to review available and emerging evidence and develop expert consensus recommendations regarding harmonization of patient/family education practices for newly diagnosed pediatric oncology patients across institutions. Five broad principles, with associated recommendations, were identified by the panel, including recognition that (1) in pediatric oncology, patient/family education is family-centered; (2) a diagnosis of childhood cancer is overwhelming and the family needs time to process the diagnosis and develop a plan for managing ongoing life demands before they can successfully learn to care for the child; (3) patient/family education should be an interprofessional endeavor with 3 key areas of focus: (a) diagnosis/treatment, (b) psychosocial coping, and (c) care of the child; (4) patient/family education should occur across the continuum of care; and (5) a supportive environment is necessary to optimize learning. Dissemination and implementation of these recommendations will set the stage for future studies that aim to develop evidence to inform best practices, and ultimately to establish the standard of care for effective patient/family education in pediatric oncology

    Characteristic Processes in Close Peer Friendships of Preterm Infants at Age 12

    Get PDF
    Close friendships become important at middle-school age and are unexplored in adolescents born prematurely. The study aimed to characterize friendship behaviors of formerly preterm infants at age 12 and explore similarities and differences between preterm and full-term peers on dyadic friendship types. From the full sample of N = 186, one hundred sixty-six 12-year-old adolescents (40 born full term, 126 born preterm) invited a close friend to a 1.5 hour videotaped laboratory play session. Twenty adolescents were unable to participate due to scheduling conflicts or developmental disability. Characteristic friendship behaviors were identified by Q-sort followed by Q-factoring analysis. Friendship duration, age, and contact differed between the full-term and preterm groups but friendship activities, behaviors, and quality were similar despite school service use. Three Q-factors, leadership, distancing, and mutual playfulness, were most characteristic of all dyads, regardless of prematurity. These prospective, longitudinal findings demonstrate diminished prematurity effects at adolescence in peer friendship behavior and reveal interpersonal dyadic processes that are important to peer group affiliation and other areas of competence

    Sex-Specific Differences in Heart Failure:Pathophysiology, Risk Factors, Management, and Outcomes

    Get PDF
    Heart failure (HF) is a leading cause of hospitalisation, morbidity, and mortality in Canada. There are sex-specific differences in the etiology, epidemiology, comorbidities, treatment response, and treatment adverse effects that have implications on outcomes in HF. Sex-specific analyses of some HF trials indicate that optimal doses of drug therapies and benefit of device therapies may differ between male and female patients, but the trials were not designed to test sex differences. The under-representation of female participants in HF randomised controlled trials (RCTs) is a major limitation in assessing the sex-specific efficacy and safety of treatments. To ensure that female patients receive safe and effective HF therapies, RCTs should include participants proportionate to the sex-specific distribution of disease. This review outlines the sex-specific differences in HF phenotype and treatment response, and highlights disparities in services and gaps in knowledge that merit further investigation

    Leveraging mobile health technology and research methodology to optimize patient education and self-management support for advanced cancer pain

    Get PDF
    Funding: National Institutes of Health [R21 NR017745, PI, Enzinger]; Friends of Dana-Farber Cancer Institute. Availability of data and material: The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.Peer reviewedPostprin
    corecore